Joint (JYNT) Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" JYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JYNT, but not buy additional shares or sell existing shares.
View JYNT analyst ratings or view top-rated stocks.

3 brokerages have issued 1 year price objectives for Joint's stock. Their JYNT share price forecasts range from $15.00 to $26.00. On average, they expect the company's share price to reach $19.00 in the next twelve months. This suggests a possible upside of 88.9% from the stock's current price.
View analysts price targets for JYNT or view top-rated stocks among Wall Street analysts.

Joint's stock was trading at $13.98 at the start of the year. Since then, JYNT stock has decreased by 28.0% and is now trading at $10.06.
View the best growth stocks for 2023 here.

The Joint Corp. (NASDAQ:JYNT) posted its earnings results on Thursday, November, 4th. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.04 by $0.09. The firm had revenue of $20.99 million for the quarter, compared to analysts' expectations of $19.48 million. Joint had a trailing twelve-month return on equity of 11.38% and a net margin of 3.41%. During the same period in the previous year, the company earned $0.11 earnings per share.

87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), RTX (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE).

(JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Joint's stock is owned by a number of institutional and retail investors. Top institutional investors include Bandera Partners LLC (18.05%), BlackRock Inc. (6.95%), Skylands Capital LLC (2.74%), Geode Capital Management LLC (1.91%), O Brien Greene & Co. Inc (1.86%) and Dimensional Fund Advisors LP (1.80%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella.
View institutional ownership trends.

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of JYNT stock can currently be purchased for approximately $10.06.

Joint (NASDAQ:JYNT) has a market capitalization of $147.68 million and generates $101.91 million in revenue each year. The company earns $1.18 million in net income (profit) each year or $0.24 on an earnings per share basis.

The company employs 359 workers across the globe.

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The official website for the company is www.thejoint.com. The company can be reached via phone at (480) 245-5960, via email at thejoint@lhai.com, or via fax at 480-513-7989.